Purchase Order N6809516P1508
- Not listed
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...
- This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
- This is a delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The contract is for the supply of PANOCELL I, II, III (3X10ML) medical products, with a ceiling value of $153,884.39 and a period of performance through September 30, 2021. The contract was awarded on a firm fixed-price basis without any set-aside designation....
- This federal contract award, valued at $244,758.17, was issued by the Defense Health Agency to Immucor Inc., a manufacturer of goods, for the delivery of CAP R RS (3) 5 PLATE DOMESTIC. The contract is a firm fixed-price purchase order without a set-aside designation, with a period of performance through May 31, 2024. Immucor is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The company has a history...
- This is a federal Delivery Order awarded by the Defense Health Agency to Immucor Inc., a manufacturer of in vitro diagnostic products and blood banking supplies. The contract, valued at $8,745.07, is for the provision of PANOCELL 16 16X3 products, which are likely reagents or test kits used in blood typing and compatibility testing. The contract is issued under Immucor's existing General Services Administration (GSA) Multiple Award Schedule contract for In Vitro Diagnostics, Reagents, and Test...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 9 (VISN 9) of the U.S. Department of Veterans Affairs (VA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The $14,767.48 contract is for the delivery of Immucor blood products to support the VA's blood transfusion and transplantation compatibility testing requirements. Immucor has a history of providing specialized reagents, blood analyzers, and related consumables to federal...
- This firm fixed-price federal contract award to Immucor Inc. is for the provision of in-vitro diagnostic substances and related manufacturing services. The $20,000.00 contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense, and has an ultimate completion date of September 30, 2022. The award does not have a set-aside designation. Immucor Inc. is a for-profit manufacturer specializing in automated blood testing equipment, reagents, and consumables for...
- This is a delivery order contract awarded by the Pacific Air Forces, a Defense agency, to Immucor Inc., a for-profit manufacturer, for the provision of medical and surgical instruments, equipment, and supplies. The contract has a not-to-exceed ceiling value of $83,972.72 and was awarded on a firm-fixed price basis. The contract was not set aside for any specific business type. The award appears to be issued under an existing indefinite delivery vehicle that Immucor holds, facilitating the...
- This is a firm fixed-price delivery order issued under the Invitro Diagnostics, Reagents, Test (FSS-65-VII) Federal Supply Schedule contract by the Bureau of Medicine and Surgery, a defense agency. The $166,936.02 award to Immucor Inc., a manufacturer of in vitro diagnostic products, is for the provision of CHECKCELL WEAK REAGENT (product code 0002227). The award has a period of performance through September 30, 2016 and does not utilize a set-aside designation. Immucor has a history of...
- This is a delivery order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Immucor Inc. for the annual supply of blood testing reagents. The award, which has a ceiling value of $130,059.42, is made under Immucor's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. As a firm fixed-price contract, this delivery order does not utilize any set-aside designations. Immucor is a leading provider of automated...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Immucor Inc. for the yearly supply of PANOCELL-20 and FMH RAPID SCREEN diagnostic products. The award is valued at $9,931.60 and does not have a set-aside designation. Immucor is a manufacturer of in vitro diagnostics, reagents, and equipment for blood transfusion and transplantation compatibility testing. The company has held multiple federal contracts to provide specialized medical supplies and services related to blood banking operations at various government healthcare networks and military treatment facilities. This award facilitates the recurring procurement of critical blood typing and screening products to support the agency's testing programs and healthcare services on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 10/23/15 |